Skip to content

Comparison of Radiofrequency Ablation With Concomitant or Staged Treatment for Tributary Varicose Veins

Comparison of Concomitant or Staged Treatment of Tributary Veins for Lower Extremity Varicose Veins: A Multicenter Randomized Controlled Study

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07445425
Enrollment
206
Registered
2026-03-03
Start date
2026-03-01
Completion date
2026-12-01
Last updated
2026-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Varicose Veins of Lower Limb

Brief summary

The purpose of this clinical trial is to know which is better to treat the branch vein at the same time or in stages during radiofrequency ablation. The main questions it aims to answer are: Does the patient who did not treat the branch vein in the first stage of operation need to intervene again? Are there any differences in patients' indexes between the two surgical strategies? Participants will: Radiofrequency ablation with or without foam sclerosing agent therapy One week, three months and six months after operation, go to the clinic for a reexamination. Record their symptoms

Interventions

PROCEDUREStaged surgery group

The patient is placed in the supine position, and then a DUS examination of the GSV in the affected limbs will be performed. At the appropriate site, local anesthesia will be performed, and the ultrasound-guided Seldinger technique will be used to puncture the main trunk of the GSV 10cm above and below the knee joint. When the needle puncture is successful, we will insert the guidewire, and a 7F vascular sheath (Terumo) will be inserted along the guidewire. Then, we will insert the radiofrequency catheter and advanced the tip to approximately 2 cm at the junction of the saphenofemoral vein, where it will be left in place. Under ultrasound guidance, the needle will be tightly attached to the GSV sheath, and an anesthetic solution will be injected to treat the swelling until the junction of the saphenofemoral vein will be reached. Then, we will secure the tip of the radiofrequency catheter and switch on the radiofrequency generator and ablated the primary trunk of the GSV in segments.

PROCEDUREConcomitant surgery group

While the experimental group receives ablation alone, the control group received 1% polidocanol foam sclerosant injection and/or point excision treatment for the pre-marked calf segment branches of the GSV after ablation treatment. Both groups will wear elastic bandages for 24 hours postoperatively, followed by thigh-length class II compression stockings for 1 week after bandage removal.

Sponsors

Sir Run Run Shaw Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

aged between 18 and 80 years; primary unilateral lower limb GSV varicose; hemodynamic classification I and III involvement in tributary veins, tributary veins originating within 15 cm inferior to the knee joint; clinical grade C2-C4; primary trunk diameter of GSV in thigh segment≥3mm to ≤ 15 mm; agree to participate in this study and voluntarily sign an informed consent form.

Exclusion criteria

Body Mass Index (BMI) ≥35kg/m2; severe tortuosity or tight adherence of the trunk of the GSV to the skin in the thigh; history of previous varicose vein surgery on the ipsilateral lower limb (investigator allows to be controlled); previous deep vein thrombosis and/or calf muscle venous thrombosis; uncorrectable coagulation disorders or significant blood abnormalities (platelets≤30×109/L); allergy to lidocaine or sclerosing agents; ankle-brachial index (ABI) \<0.6 and/or absolute ankle pressure \<60mmHg; pregnancy or lactation, or intend to have a child in the next year; participation in other clinical trials; anterior saphenous vein start diameter\>3.5mm; any other patients investigator considers improper to participate in this study.

Design outcomes

Primary

MeasureTime frame
The re-intervention rate1 week, 3 months and 6 months after surgery

Secondary

MeasureTime frameDescription
Treatment cost6 months after surgeryAccording to the statistics of hospital charging system
Success rate of varicose vein closure1 week, 3 months and 6 months after surgery
Operation timeDuring the operation
Number of incisionsDuring the operation
Tumescent anesthesia solution dosageDuring the operation
The amount of intraoperative bleedingDuring the operation
AVVQ scoreBefore surgery, 1 week, 3 months and 6 months after surgeryThe Aberdeen varicose vein questionnaire. The score range is 0-100, and the higher the score, the worse the result.
VAS scoreBefore surgery, 1 week, 3 months and 6 months after surgeryVisual analogue scale. The score range is 0-10, and the higher the score, the worse the result.
VCSS scoreBefore surgery, 1 week, 3 months and 6 months after surgeryVenous clinical severity score. The score range is 0-30, and the higher the score, the worse the result.
Postoperative complications1 week, 3 months and 6 months after surgery
Time to return to regular work1 week after surgery
Patient satisfactionDuring the operation and 6 months after surgeryInclude two question: "The quality of treatment that you received was good?" "The treatment that you received fulfilled your expectations?"

Countries

China

Contacts

CONTACTMeijia Xu
1341506760@qq.com+8619700777750

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 4, 2026